Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis

Clinical and Experimental Immunology

Volumn 120, Issue 1, 2000, Pages 167-173

  Hollo K ^a   Glant, Tibor T ^b,d   Garzo M ^a   Finnegan, A ^b   Mikecz, K ^b   Buzas E ^a,c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b RUSH UNIVERSITY   (United States)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aggrecan; Arthritis; Autoimmune; BALB c; Isotype; Proteoglycan; Th1 Th2

Indexed keywords

AGGRECAN; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HELPER CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 0034102866     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01174.x     Document Type: Article

References (37)

1. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 1987; 30:201-12.
2. Glant TT, Cs-Szabó G, Nagase H, Jacobs JJ, Mikecz K. Progressive polyarthritis induced in BALB/c mice by aggrecan from human osteoarthritic cartilage. Arthritis Rheum 1998; 41:1007-18.
3. Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987; 30:306-18.
4. Glant TT, Buzás EI, Finnegan A, Negroiu G, Cs-Szabó G, Mikecz K. Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol 1998; 160:3812-9.
5. Mikecz K, Glant TT, Buzás E, Poole AR. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (non-immunized) BALB/c mice. Arthritis Rheum 1990; 33:866-76.
6. + T cells. Cell Immunol 1992; 144:347-57.
7. Buzás EI, Brennan FR, Mikecz K et al. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J Immunol 1995; 155:2679-87.
8. Brennan FR, Mikecz K, Buzás EI et al. Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autoreactive T cell hybridoma derived from a mouse with proteoglycan-induced arthritis. Clin Exp Immunol 1995; 101:414-21.
9. Mosmann TR, Cherwinski H, Bond MA, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
10. Kelso A. Th1 and Th2 subsets: paradigms list? Immunol Today 1995; 16:374-9.
11. Kiely PD. The Th1-Th2 model - what relevance to inflammatory arthritis? Ann Rheum Dis 1998; 57:328-30.
12. Doncarli A, Stasiuk LM, Fournier C, Abehsira-Amar O. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur J Immunol 1997; 27:1451-8.
13. Glant TT, Mikecz K, Poole AR. Monoclonal antibodies to different protein-related epitopes of human articular cartilage proteoglycans. Biochem J 1986; 234:31-41.
14. Mikecz K, Brennan FR, Kim JH, Glant TT. Anti-CD44 treatment abrogates tissue edema and leukocyte infiltration in murine arthritis. Nature Med 1995; 1:558-63.
15. Czerkinsky C, Nilsson LA, Nygren H, Ouchterlony O, Tarkowsky A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983; 65:109-21.
16. Negroiu G, Roughley PJ, Cs-Szabó G, Brennan FR, Glant TT. Identification of autoimmune/arthritogenic epitopes of cartilage proteoglycans (PGs) using autoreactive antibodies to mouse aggrecan. Arthritis Rheum 1995; 38:S295(Abstr.).
17. Adorini L, Guery JC, Trembleau S. Manipulation of the Th1/Th2 cell balance: an approach to treat human autoimmune diseases? Autoimmunity 1996; 23:53-68.
18. Nicholson LB, Kuchroo VK. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996; 8:837-42.
19. Yu M, Johnson JM, Tuohy VK. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. J Neurosci Res 1996; 45:463-70.
20. Mauri C, Williams RO, Walmsley M, Feldman M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996; 26:1511-8.
21. De Franco M, Gille-Perramant MF, Mevel JC, Couderc J. T helper subset involvement in two high antibody responder lines of mice (Biozzi mice): HI (susceptible) and HII (resistant) to collagen-induced arthritis. Eur J Immunol 1995; 25:132-6.
22. 1 mice. J Immunol 1997; 158:1466-72.
23. Ausubel LJ, Krieger JI, Hafler DA. Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99. J Immunol 1997; 159:2502-12.
24. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994; 91:8562-6.
25. van Roon JAG, van Roy JL, Duits A, Lafeber FP, Bijlsma JW. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4. Ann Rheum Dis 1995; 54:836-40.
26. Dolhain RJ, van der Heiden AN, tel Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:1961-9.
27. van Roon JAG, Verhoef CM, van Roy JL et al. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Ann Rheum Dis 1997; 56:656-60.
28. Haddad A, Bienvenu J, Miossec P. Increased production of a Th2 cytokine profile by activated whole blood cells from rheumatoid arthritis patients. J Clin Immunol 1998; 18:399-403.
29. Isomäki P, Luukkainen R, Lassila O, Toivanen P, Punnonen J. Synovial fluid T cells from patients with rheumatoid arthritis are refractory to the T helper type 2 differentiation-inducing effects of interleukin-4. Immunology 1999; 96:358-64.
30. Jacobs MJM, Van Den Hoek AEM, van Lent PLEM, van de Loo FAJ, van de Putte LBA, van den Berg WB. Role of IL-2 and IL-4 in exacerbations of murine antigen-induced arthritis. Immunology 1994; 83:390-6.
31. Müssener Å, Litton MJ, Lindroos E, Klareskog L. Cytokine production in synovial tissue of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 1997; 107:485-93.
32. Pearson CI, McDevitt HO. Redirecting Th1 and Th2 responses in autoimmune disease. Curr Opin Microbiol Immunol 1999; 238:79-122.
33. Van der Graaff WL, Prins APA, Dijkmans BAC, van Lier RAW. Prognostic value of Th1/Th2 ratio in rheumatoid arthritis. Lancet 1998; 351:1931.
34. Beech JT, Siew LK, Ghoraishian M, Stasiuk LM, Elson CJ, Thompson SJ. CD4+ Th2 cells specific for mycobacterial 65-kilodalton heat shock protein protect against pristane-induced arthritis. J Immunol 1997; 159:3692-7.
35. Kageyama Y, Koide Y, Yoshida A et al. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-gamma receptor. J Immunol 1998; 161:1542-8.
36. Kusaba M, Honda J, Fukuda T, Oizumi K. Analysis of type I and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. J Rheumatol 1998; 25:1466-71.
37. Van der Graaff WL, Prins APA, Niers TMH, Dijkmans BAC, van Lier RAW. Quantitation of Interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. Rheumatology 1999; 38:214-20.